A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters

The development of an effective vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), is a global priority. Here, we compare the protective capacity of intranasal and intramuscular delivery of a chimpanzee adenovirus...

Descripción completa

Detalles Bibliográficos
Autores principales: Bricker, Traci L., Darling, Tamarand L., Hassan, Ahmed O., Harastani, Houda H., Soung, Allison, Jiang, Xiaoping, Dai, Ya-Nan, Zhao, Haiyan, Adams, Lucas J., Holtzman, Michael J., Bailey, Adam L., Case, James Brett, Fremont, Daved H., Klein, Robyn, Diamond, Michael S., Boon, Adrianus C.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238649/
https://www.ncbi.nlm.nih.gov/pubmed/34245672
http://dx.doi.org/10.1016/j.celrep.2021.109400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238649/
https://www.ncbi.nlm.nih.gov/pubmed/34245672
http://dx.doi.org/10.1016/j.celrep.2021.109400

Ejemplares similares